A nurse is preparing a client for a kidney biopsy. Which of the following client conditions should the nurse identify as a contraindication for this diagnostic test?
Flank pain
Elevated creatinine level
Coagulation disorder
Urinary retention
The Correct Answer is C
Rationale:
A. Flank pain alone is not a contraindication for a kidney biopsy, although it may be a symptom that necessitates the biopsy to determine the cause of kidney issues.
B. An elevated creatinine level indicates impaired kidney function but is not a contraindication for a kidney biopsy; in fact, it may be a reason to perform the biopsy.
C. A coagulation disorder is a contraindication for a kidney biopsy because it increases the risk of bleeding during and after the procedure. It is crucial to ensure that coagulation parameters are within a safe range before performing this invasive test.
D. Urinary retention does not contraindicate a kidney biopsy, although it may need to be addressed separately.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
Rationale:
A. Hemoglobin A1C reflects average blood glucose levels over the past 2 to 3 months, not just after meals, so this statement is not fully accurate.
B. A high A1C indicates chronically high blood glucose levels, not low blood sugar levels, so this statement would be misleading.
C. An A1C of 9% indicates that the client's average blood sugar has been high over the past few months, which increases the risk of diabetes-related complications.
D. While a high A1C may suggest variability in blood glucose levels, the more accurate statement is that the average blood glucose is high, which is what the A1C primarily reflects
Correct Answer is A
Explanation
Rationale:
A. Epoetin alfa is used to stimulate the production of red blood cells, so an increase in hematocrit levels would indicate a therapeutic effect. This is particularly important in clients with chronic renal disease, who often suffer from anemia due to decreased erythropoietin production by the kidneys.
B. The erythrocyte sedimentation rate (ESR) is a nonspecific measure of inflammation and is not used to monitor the effectiveness of epoetin alfa therapy.
C. The leukocyte count measures white blood cells and is not affected by or used to assess the effectiveness of epoetin alfa.
D. The platelet count measures platelets in the blood and is not related to the therapeutic effects of epoetin alfa, which targets red blood cell production.